HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
about
Immunologic aspect of ovarian cancer and p53 as tumor antigen.T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesTumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerSpectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemiaRelationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.In vivo expression of MHC class I genes depends on the presence of a downstream barrier elementMolecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomasEngineered T cells for cancer therapy.Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease.HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinomaStrategies and developments of immunotherapies in osteosarcomaMultifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulationDownregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy.Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms.Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sites.c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cellsAnti-tumor immunostimulatory effect of heat-killed tumor cells.Clinical impact of HLA class I expression in rectal cancer.Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer.
P2860
Q24814703-B2CDE9A2-67FE-4B16-B651-8A533E559C7DQ28074619-F61CBBEA-C5D5-4902-9524-9A0107636407Q28238067-7BF8B4D7-C6C2-41C2-9DB0-A34A8282BD90Q28384290-3BD3C701-5DE0-47FA-8886-B3262A9EAB14Q30425423-090FCCEA-4AFB-4C6E-8CD2-32D08B5332C5Q33496784-8D2B7FE0-95B3-409D-B4FB-A8F5956E841CQ33748623-0A54BFF7-9C06-4C06-9A1D-C1D3B939810DQ33758727-5F792DC8-EC11-462A-9E90-9C999F9F70A1Q34080368-B335EBC9-19CF-4B1C-9F64-0E246C58B70FQ34178740-DA372D5A-6475-4A35-8660-81530482DB1BQ36184723-5CC86B50-085D-474E-8FA9-EF9B7FA199C2Q36503128-82AADACE-A75D-4243-853B-C0CEB146EA20Q36673709-C367AF22-C139-473D-89A8-E4C0D520413CQ36965049-E93EDB25-C279-4465-965C-689460F8E92EQ36979335-4AD6DA81-A84A-4067-A469-E767C0744506Q37257207-9E15C9F0-CC65-4F99-A0FB-239E03191040Q37401538-9D231A0A-DCC9-4440-B5AA-7CF8B0804CAFQ37459636-C825BE97-C899-42CD-9A1C-C077AB56EF20Q37703330-B57117DB-E167-45C7-82C4-451D3FAAE1C9Q38161367-7BCAEC44-2047-401E-9848-4F508FD68FDCQ38933648-CFB306B7-A117-4BE4-AEDD-FF9CDFC1D14CQ39347865-13CBC25E-9EC0-4AB8-A7E5-097DCFFF72B7Q40008171-7382BEFE-CE21-4FDB-BB5A-AA7CBA6344D6Q40173498-63DE9BA9-F882-4824-B037-808AD135420EQ41298215-2823FB59-998C-41A3-BD4C-565A406ED0B7Q41337940-9840C549-7417-408A-885E-B8E20D5A99FEQ41592674-6A869784-34B0-4DD5-9669-7C2E21B26DB2
P2860
HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
HLA class I antigen down-regul ...... ssociation with disease stage.
@en
type
label
HLA class I antigen down-regul ...... ssociation with disease stage.
@en
prefLabel
HLA class I antigen down-regul ...... ssociation with disease stage.
@en
P2093
P1476
HLA class I antigen down-regul ...... association with disease stage
@en
P2093
Beatrice Taroni
Cristina Micheloni
Francesco Donato
Giuliana Gobbi
Giuseppe Pelusi
Marco Vitale
Rita Rezzani
Soldano Ferrone
Xinhui Wang
P407
P577
2005-01-01T00:00:00Z